Previous 10 | Next 10 |
Summary Medical devices manufacturer Smith & Nephew (S&N) has seen its shares sliding. I do not yet see the growth the company is targeting, but business has been recovering and its interim figures were decent if nothing special. Smith & Nephew's lack of clear grow...
Smith+Nephew first to market with revision knee indication on robotics platform PR Newswire LONDON , Sept. 26, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the first cases for revision knee repla...
Smith+Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies PR Newswire LONDON , Sept. 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology ...
New randomized controlled trial shows that addition of Smith+Nephew's REGENETEN™ Bioinductive Implant delivers 86% reduction in rotator cuff re-tear rates at 12 months PR Newswire LONDON , Sept. 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE: ...
Smith+Nephew's OXINIUM™ Technology Tour of Change touches down at the Pro Football Hall of Fame during enshrinement weekend PR Newswire LONDON , Aug. 4, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company,...
Smith & Nephew plc (SNN) Q2 2022 Results Conference Call July 28, 2022 03:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Conference Call Participants Patrick Wood - Bank of America ...
Smith & Nephew press release ( NYSE: SNN ): 1H Non-GAAP EPS of 38.10c. Revenue of $2.6B (flat Y/Y) misses by $30M . 2022 Full Year Outlook ● Unchanged full-year underlying revenue growth guidance of 4.0% to 5.0% ● Trading profit margin now...
We believe the healthcare sector's strong growth momentum with average revenue growth of 3.8% QoQ indicates a positive outlook, with the equipment industry forecasted at a market CAGR of 5.5%. For the healthcare equipment industry, we believe the outlook is supported by the average gu...
Smith & Nephew ( NYSE: SNN ) is scheduled to announce 1H earnings results on Thursday, July 28th, before market open. The consensus EPS Estimate is $0.78 and the consensus Revenue Estimate is $2.63B (+1.2% Y/Y). Over the last 1 year, SNN has beaten EPS estimates ...
OTCQX:AAUKF , ABEV , ABG , AGCO , OTCPK:AIQUF , ALGM , ALLE , ALNY , AMT , AOS , ARCH , ARES , ARGX , ASPS , ASX , OTCPK:ATGFF , ATNX , BAX , BC , BCS , BEN , BFH , BPOP , BT , BTU , BUD ...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...